DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight

Abstract

Over recent years, within the community of radiopharmaceutical sciences, there has been an increased incidence of incorrect usage of established scientific terms and conventions, and even the emergence of ‘self-invented’ terms. Here, in order to address these concerns, an international Working Group on ‘Nomenclature in Radiopharmaceutical Chemistry and related areas’ was established in 2015 to achieve clarification of terms and to generate consensus on the utilisation of a standardised nomenclature pertinent to the field. Upon open consultation, the following consensus guidelines were agreed, which aim to: Provide a reference source for nomenclature good practice in the radiopharma-ceutical sciences; Clarify the use of terms and rules concerning exclusively radiopharmaceutical terminology, i.e. nuclear- and radiochemical terms, symbols and expressions; Address gaps and inconsistencies in existing radiochemistry nomenclature rules; Provide source literature for further harmonisation beyond our immediate peer group (publishers, editors, IUPAC, pharmacopoeias, etc.).

Authors:
 [1]; ORCiD logo [2];  [3];  [4];  [5];  [6];  [7];  [8];  [9];  [10];  [11]
  1. Forschungszentrum Julich (Germany)
  2. King's College London (United Kingdom)
  3. TRIUMF, Vancouver, BC (Canada)
  4. Uppsala Univ. (Sweden)
  5. Brookhaven National Lab. (BNL), Upton, NY (United States)
  6. Keio Univ., Tokyo (Japan)
  7. Seoul National Univ., Seoul (South Korea)
  8. Univ. of Pennsylvania, Philadelphia, PA (United States)
  9. Ludwig Boltzmann Inst. Applied Diagnostics, Vienna (Austria)
  10. National Inst. of Mental Health, Bethesda, MD (United States)
  11. VU Univ. Medical Centre, Amsterdam (The Netherlands)
Publication Date:
Research Org.:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Nuclear Physics (NP)
OSTI Identifier:
1413925
Report Number(s):
BNL-114441-2017-JA
Journal ID: ISSN 0969-8051; R&D Project: KBCH139; KB0202011; TRN: US1800586
Grant/Contract Number:  
SC0012704
Resource Type:
Accepted Manuscript
Journal Name:
Nuclear Medicine and Biology
Additional Journal Information:
Journal Volume: 55; Journal Issue: C; Journal ID: ISSN 0969-8051
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
38 RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEAR CHEMISTRY; nomenclature; terminology; consensus guidelines; radiopharmaceutical sciences; nuclear chemistry; radiochemistry

Citation Formats

Coenen, Heinz H., Gee, Antony D., Adam, Michael, Antoni, Gunnar, Cutler, Cathy S., Fujibayashi, Yasuhisa, Jeong, Jae Min, Mach, Robert H., Mindt, Thomas L., Pike, Victor W., and Windhorst, Albert D. Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight. United States: N. p., 2017. Web. doi:10.1016/j.nucmedbio.2017.09.004.
Coenen, Heinz H., Gee, Antony D., Adam, Michael, Antoni, Gunnar, Cutler, Cathy S., Fujibayashi, Yasuhisa, Jeong, Jae Min, Mach, Robert H., Mindt, Thomas L., Pike, Victor W., & Windhorst, Albert D. Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight. United States. https://doi.org/10.1016/j.nucmedbio.2017.09.004
Coenen, Heinz H., Gee, Antony D., Adam, Michael, Antoni, Gunnar, Cutler, Cathy S., Fujibayashi, Yasuhisa, Jeong, Jae Min, Mach, Robert H., Mindt, Thomas L., Pike, Victor W., and Windhorst, Albert D. Sat . "Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight". United States. https://doi.org/10.1016/j.nucmedbio.2017.09.004. https://www.osti.gov/servlets/purl/1413925.
@article{osti_1413925,
title = {Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight},
author = {Coenen, Heinz H. and Gee, Antony D. and Adam, Michael and Antoni, Gunnar and Cutler, Cathy S. and Fujibayashi, Yasuhisa and Jeong, Jae Min and Mach, Robert H. and Mindt, Thomas L. and Pike, Victor W. and Windhorst, Albert D.},
abstractNote = {Over recent years, within the community of radiopharmaceutical sciences, there has been an increased incidence of incorrect usage of established scientific terms and conventions, and even the emergence of ‘self-invented’ terms. Here, in order to address these concerns, an international Working Group on ‘Nomenclature in Radiopharmaceutical Chemistry and related areas’ was established in 2015 to achieve clarification of terms and to generate consensus on the utilisation of a standardised nomenclature pertinent to the field. Upon open consultation, the following consensus guidelines were agreed, which aim to: Provide a reference source for nomenclature good practice in the radiopharma-ceutical sciences; Clarify the use of terms and rules concerning exclusively radiopharmaceutical terminology, i.e. nuclear- and radiochemical terms, symbols and expressions; Address gaps and inconsistencies in existing radiochemistry nomenclature rules; Provide source literature for further harmonisation beyond our immediate peer group (publishers, editors, IUPAC, pharmacopoeias, etc.).},
doi = {10.1016/j.nucmedbio.2017.09.004},
journal = {Nuclear Medicine and Biology},
number = C,
volume = 55,
place = {United States},
year = {Sat Oct 21 00:00:00 EDT 2017},
month = {Sat Oct 21 00:00:00 EDT 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 102 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Glossary of terms used in nuclear analytical chemistry (Provisional)
journal, January 1982


Nomenclature for radioanalytical chemistry (IUPAC Recommendations 1994)
journal, January 1994


How do we define the concepts specific activity, radioactive concentration, carrier, carrier-free and no-carrier-added?
journal, January 2005

  • de Goeij, J. J. M.; Bonardi, M. L.
  • Journal of Radioanalytical and Nuclear Chemistry, Vol. 263, Issue 1
  • DOI: 10.1007/s10967-005-0004-6

N.c.a. radiosynthesis of [123,124I]β-CIT, plasma analysis and pharmacokinetic studies with SPECT and PET
journal, November 1995


Factors affecting the specific activity of [18F]fluoride from a [18O]water target
journal, January 2008

  • Füchtner, F.; Preusche, S.; Mäding, P.
  • Nuklearmedizin, Vol. 47, Issue 03
  • DOI: 10.3413/nukmed-0133

True radiotracers: are we approaching theoretical specific activity with Tc-99m and I-123?
journal, July 2008


A historical perspective on the specific activity of radiopharmaceuticals: What have we learned in the 35years of the ISRC?
journal, April 2013


Definitions of radioisotope thick target yields
journal, January 2015


Works referencing / citing this record:

Radiosynthesis of an 18 F-fluoroglycosylated aminoferrocene for in-vivo imaging of reactive oxygen species activity by PET
journal, October 2018

  • Toms, Johannes; Reshetnikov, Viktor; Maschauer, Simone
  • Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 61, Issue 14
  • DOI: 10.1002/jlcr.3687

Microfluidic 68 Ga-labeling: a proof of principle study
journal, January 2018

  • Pfaff, Sarah; Philippe, Cecile; Pichler, Verena
  • Dalton Transactions, Vol. 47, Issue 17
  • DOI: 10.1039/c8dt00158h

Radiometals for imaging and theranostics, current production, and future perspectives
journal, July 2019

  • Mikolajczak, Renata; van der Meulen, Nicholas P.; Lapi, Suzanne E.
  • Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 62, Issue 10
  • DOI: 10.1002/jlcr.3770

Rapid and Efficient Synthesis of 11 C-Labeled Benzimidazolones Using [ 11 C]Carbon Dioxide
journal, February 2019


Guidelines for the content and format of PET brain data in publications and archives: A consensus paper
journal, February 2020

  • Knudsen, Gitte M.; Ganz, Melanie; Appelhoff, Stefan
  • Journal of Cerebral Blood Flow & Metabolism, Vol. 40, Issue 8
  • DOI: 10.1177/0271678x20905433

Pitfalls and solutions of the fully-automated radiosynthesis of [11C]metoclopramide
journal, December 2019

  • Pichler, Verena; Ozenil, Marius; Bamminger, Karsten
  • EJNMMI Radiopharmacy and Chemistry, Vol. 4, Issue 1
  • DOI: 10.1186/s41181-019-0083-2

Direct arene C–H fluorination with 18 F via organic photoredox catalysis
journal, June 2019


Characterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors
journal, February 2018


Reaction of 11 C-benzoyl chlorides with metalloid reagents: 11 C-labeling of benzyl alcohols, benzaldehydes, and phenyl ketones from [ 11 C]CO
journal, February 2018

  • Roslin, Sara; Dahl, Kenneth; Nordeman, Patrik
  • Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 61, Issue 5
  • DOI: 10.1002/jlcr.3609

Palladium( ii )-mediated rapid 11 C-cyanation of (hetero)arylborons
journal, January 2018

  • Zhang, Zhouen; Niwa, Takashi; Watanabe, Yasuyoshi
  • Organic & Biomolecular Chemistry, Vol. 16, Issue 41
  • DOI: 10.1039/c8ob02049c

Rhodium-mediated 18 F-oxyfluorination of diazoketones using a fluorine-18-containing hypervalent iodine reagent
journal, January 2019

  • Cortés González, Miguel A.; Jiang, Xingguo; Nordeman, Patrik
  • Chemical Communications, Vol. 55, Issue 89
  • DOI: 10.1039/c9cc06905d

Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
journal, July 2019


Toward the Optimization of (+)-[ 11 C]PHNO Synthesis: Time Reduction and Process Validation
journal, September 2019

  • Pfaff, Sarah; Philippe, Cécile; Nics, Lukas
  • Contrast Media & Molecular Imaging, Vol. 2019
  • DOI: 10.1155/2019/4292596

Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
journal, April 2019

  • Coenen, Heinz H.; Gee, Antony D.; Adam, Michael
  • EJNMMI Radiopharmacy and Chemistry, Vol. 4, Issue 1
  • DOI: 10.1186/s41181-018-0047-y

Defining Processing Times for Accelerator Produced 225Ac and Other Isotopes from Proton Irradiated Thorium
journal, March 2019


Fully-automated radiosynthesis of the amyloid tracer [11C] PiB via direct [11C]CO2 fixation-reduction
journal, July 2019

  • Buccino, Pablo; Savio, Eduardo; Porcal, Williams
  • EJNMMI Radiopharmacy and Chemistry, Vol. 4, Issue 1
  • DOI: 10.1186/s41181-019-0065-4

Reliable radiosynthesis of 4-[10B]borono-2-[18F]fluoro-l-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis
journal, June 2018

  • Ishiwata, Kiichi; Ebinuma, Ryoichi; Watanabe, Chuichi
  • Annals of Nuclear Medicine, Vol. 32, Issue 7
  • DOI: 10.1007/s12149-018-1268-6

Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
journal, January 2020


Rapid one-step 18F-radiolabeling of biomolecules in aqueous media by organophosphine fluoride acceptors
journal, March 2019


Open letter to journal editors on: International consensus radiochemistry nomenclature guidelines
journal, April 2018

  • Coenen, Heinz H.; Gee, Antony D.; Adam, Michael
  • Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 61, Issue 4
  • DOI: 10.1002/jlcr.3604

Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
journal, February 2018

  • Coenen, Heinz H.; Gee, Antony D.; Adam, Michael
  • Annals of Nuclear Medicine, Vol. 32, Issue 3
  • DOI: 10.1007/s12149-018-1238-z

Fully-automated radiosynthesis of the amyloid tracer [11C] PiB via direct [11C]CO2 fixation-reduction
journal, July 2019

  • Buccino, Pablo; Savio, Eduardo; Porcal, Williams
  • EJNMMI Radiopharmacy and Chemistry, Vol. 4, Issue 1
  • DOI: 10.1186/s41181-019-0065-4

Pitfalls and solutions of the fully-automated radiosynthesis of [11C]metoclopramide
journal, December 2019

  • Pichler, Verena; Ozenil, Marius; Bamminger, Karsten
  • EJNMMI Radiopharmacy and Chemistry, Vol. 4, Issue 1
  • DOI: 10.1186/s41181-019-0083-2

2-(4-Methylsulfonylphenyl)pyrimidines as Prospective Radioligands for Imaging Cyclooxygenase-2 with PET—Synthesis, Triage, and Radiolabeling
journal, November 2018


Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
journal, January 2020


Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
journal, July 2019